Similar articles

• [Immunological abnormalities in neuromuscular diseases].

  Nishitani H, Saida T, Ohta M, Kuno S. Nishitani H, et al. No To Shinkei. 1983 Jun;35(6):543-51. No To Shinkei. 1983. PMID: 6354220 Review. Japanese. No abstract available.
• [Immunologic pathology in patients with disorders of neuromuscular transmission].

  Kolomenskaia EA, Shagal DI, Strokov IA, Evseev VA. Kolomenskaia EA, et al. Zh Nevropatol Psikhiatr Im S S Korsakova. 1984;84(4):481-6. Zh Nevropatol Psikhiatr Im S S Korsakova. 1984. PMID: 6730812 Russian.
• [A case of myasthenia gravis occurring in the period of remission of chronic inflammatory demyelinating polyradiculoneuropathy].

  Inatus A, Ohi T, Shioya K, Matsukura S. Inatus A, et al. Rinsho Shinkeigaku. 1992 Aug;32(8):878-9. Rinsho Shinkeigaku. 1992. PMID: 1490316 Japanese.
• [Experiences with high dosage immunoglobulin G in neuromuscular diseases].

  Schuchardt V, Hotz M, Hund E, Sun S, Heitmann R, Hacke W. Schuchardt V, et al. Nervenarzt. 1993 Feb;64(2):98-103. Nervenarzt. 1993. PMID: 8450901 German.
• Immunologic aspects of neurological and neuromuscular diseases.

  Zweiman B, Arnason BG. Zweiman B, et al. JAMA. 1987 Nov 27;258(20):2970-3. JAMA. 1987. PMID: 3312680 Review. No abstract available.